Treatment Practice and Analysis under the Collaboration between Doctors and Pharmacists in Patient with Diffuse Large B-Cell Lymphoma Complicated by Severe Renal Insufficiency

Background The main treatment for diffuse large B-cell lymphoma is immunochemotherapy. However, the transport of most chemotherapy drugs in the body relies on the participation of the kidneys. For patients with diffuse large B-cell lymphoma, the coexistence of severe renal insufficiency undoubtedly poses a significant challenge to treatment. During the treatment process, doctors and pharmacists need to closely cooperate to maximize the therapeutic benefits for patients while ensuring their safet